WordNet

street name for lysergic acid diethylamide (同)back breaker, battery-acid, dose, dot, Elvis, loony toons, Lucy in the sky with diamonds, pane, superman, window pane, Zen
any of various water-soluble compounds having a sour taste and capable of turning litmus red and reacting with a base to form a salt
having the characteristics of an acid; "an acid reaction"
resulting from or employing derivation; "a derivative process"; "a highly derivative prose style"
a compound obtained from, or regarded as derived from, another compound
(linguistics) a word that is derived from another word; "`electricity is a derivative of `electric"

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.

Leonard CE1,2, Bilker WB1,2,3, Brensinger CM1, Han X1,2, Flory JH2,4, Flockhart DA2,5, Gagne JJ6, Cardillo S2,7, Hennessy S1,2,8.
Clinical pharmacology and therapeutics.Clin Pharmacol Ther.2015 Nov 13. doi: 10.1002/cpt.297. [Epub ahead of print]
BACKGROUND: Drug-drug interactions causing severe hypoglycemia due to antidiabetic drugs is a major clinical and public health problem. We assessed whether sulfonylurea use with a statin or fibrate was associated with severe hypoglycemia.METHODS: We conducted cohort studies of users of glyburide, gl
PMID 26566262

Miller ML1, Wright CC2, Browne B3.
Journal of clinical lipidology.J Clin Lipidol.2015 Sep-Oct;9(5 Suppl):S67-76. doi: 10.1016/j.jacl.2015.06.013. Epub 2015 Jul 2.
As demonstrated by the 2011 publication of the National Heart, Lung, and Blood Institute Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, the information available regarding the treatment of pediatric lipid disorders has greatly expanded. HMG-CoA reduct
PMID 26343214

Agapakis DI1, Massa EV2.
Puerto Rico health sciences journal.P R Health Sci J.2015 Sep;34(3):170-3.
Fenofibrate is widely prescribed as a hypolipidemic drug and is well tolerated by most patients. We present the case of a 40-year-old woman who developed severe immune thrombocytopenia while on fenofibrate treatment. Clinical features included spontaneous bruising on the feet and hands, a purpuric r
PMID 26356743

Fenofibrate-Induced Acute Renal Failure Due to Massive Rhabdomyolysis after Coadministration of Statin in Two Patients

Evaluation of the phototoxic properties of some hypolipidemics in vitro : fenofibrate exhibits a prominent phototoxic potential in the UVA and UVB region